DEVICE APPROVAL PROCESSES
\dɪvˈa͡ɪs ɐpɹˈuːvə͡l pɹˈə͡ʊsɛsɪz], \dɪvˈaɪs ɐpɹˈuːvəl pɹˈəʊsɛsɪz], \d_ɪ_v_ˈaɪ_s ɐ_p_ɹ_ˈuː_v_əl p_ɹ_ˈəʊ_s_ɛ_s_ɪ_z]\
Sort: Oldest first
-
Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.